Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2026-02-06 @ 7:57 AM
Study NCT ID:
NCT03763604
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2024-12-16
First Post:
2018-12-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Cancer | View |
Keywords: